The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

Five different eye drop products that were sold between May 2023 and April 2025 were identified in a recall from manufacturer ...

Transportation Secretary Sean Duffy says he plans to reduce the number of flights in and out of Newark’s airport for the ...

In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much ...

The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

All the schools in these areas were closed after Pakistan began intense artillery shelling following India's launch of ...

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the crown jewel of US biomedical research with ideology and cronyism.

Vinay Prasad will replace Marks as CBER director Trump's budget would be "catastrophic" for federal R&D Pharma still in waiting mode after UK-US trade agreement ...

Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest ...